Article info

other Versions

PDF
Letter
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis

Authors

  1. Correspondence to Emanuel Della-Torre, Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS-San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy; dellatorre.emanuel{at}hsr.it
View Full Text

Citation

Della-Torre E, Campochiaro C, Cassione EB, et al
Intrathecal rituximab for IgG4-related hypertrophic pachymeningitis

Publication history

  • Received May 25, 2017
  • Revised July 24, 2017
  • Accepted July 27, 2017
  • First published August 17, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.